Cargando…

Use of inhaled corticosteroids and risk of acquiring Pseudomonas aeruginosa in patients with chronic obstructive pulmonary disease

BACKGROUND: Inhaled corticosteroids (ICS) are commonly used to treat COPD and are associated with increased risk of pneumonia. The aim of this study was to assess if accumulated use of ICS is associated with a dose-dependent risk of a positive airway culture with Pseudomonas aeruginosa in patients w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eklöf, Josefin, Ingebrigtsen, Truls Sylvan, Sørensen, Rikke, Saeed, Mohamad Isam, Alispahic, Imane Achir, Sivapalan, Pradeesh, Boel, Jonas Bredtoft, Bangsborg, Jette, Ostergaard, Christian, Dessau, Ram Benny, Jensen, Ulrich Stab, Hansen, Ejvind Frausing, Lapperre, Therese Sophie, Meteran, Howraman, Wilcke, Torgny, Seersholm, Niels, Jensen, Jens-Ulrik Stæhr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Chronic Obstructive Pulmonary Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120392/ https://www.ncbi.nlm.nih.gov/pubmed/34446524 http://dx.doi.org/10.1136/thoraxjnl-2021-217160

Ejemplares similares

Recent developments in the management of severe asthma
por: Meteran, Howraman, et al.
Publicado: (2022)

Inhaled corticosteroids and risk of lower respiratory tract infection with Moraxella catarrhalis in patients with chronic obstructive pulmonary disease
por: Johnsen, Rikke Helin, et al.
Publicado: (2023)

COPD exacerbations: the impact of long versus short courses of oral corticosteroids on mortality and pneumonia: nationwide data on 67 000 patients with COPD followed for 12 months
por: Sivapalan, Pradeesh, et al.
Publicado: (2019)

Inhalation devices and inhaled corticosteroids particle size influence on severe pneumonia in patients with chronic obstructive pulmonary disease: a nationwide cohort study
por: Heerfordt, Christian Kjer, et al.
Publicado: (2023)

Treatment Response Biomarkers in Asthma and COPD
por: Meteran, Howraman, et al.
Publicado: (2021)

Roflumilast in Severely Ill Patients with Chronic Obstructive Pulmonary Disease with Frequent Exacerbations: Risk of Pneumonia Hospitalization and Severe Exacerbations
por: Alispahic, Imane Achir, et al.
Publicado: (2020)

The Association between Use of ICS and Psychiatric Symptoms in Patients with COPD—A Nationwide Cohort Study of 49,500 Patients
por: Jordan, Alexander, et al.
Publicado: (2021)

Depressive symptoms among patients with COPD according to smoking status: a Danish nationwide case–control study of 21 184 patients
por: Vestergaard, Jakob Hedemark, et al.
Publicado: (2020)

Use of Inhaled Corticosteroids and Risk of Acquiring Haemophilus influenzae in Patients with Chronic Obstructive Pulmonary Disease
por: Mohsin, Raza Ul, et al.
Publicado: (2022)

Mortality and exacerbations associated with Stenotrophomonas maltophilia in chronic obstructive pulmonary disease. A regional cohort study of 22,689 outpatients
por: Rønn, Christian, et al.
Publicado: (2023)

Systemic Corticosteroids and the Risk of Venous Thromboembolism in Patients with Severe COPD: A Nationwide Study of 30,473 Outpatients
por: Rastoder, Ema, et al.
Publicado: (2021)

Antibiotic treatment in acute exacerbation of COPD: patient outcomes with amoxicillin vs. amoxicillin/clavulanic acid—data from 43,636 outpatients
por: Bagge, Kristian, et al.
Publicado: (2021)

Inhaled Corticosteroids in Patients with Chronic Obstructive Pulmonary Disease and Risk of Acquiring Streptococcus pneumoniae Infection. A Multiregional Epidemiological Study
por: Heerfordt, Christian Kjer, et al.
Publicado: (2023)

A multi-center randomized, controlled, open-label trial evaluating the effects of eosinophil-guided corticosteroid-sparing therapy in hospitalised patients with COPD exacerbations – The CORTICO steroid reduction in COPD (CORTICO-COP) study protocol
por: Sivapalan, Pradeesh, et al.
Publicado: (2017)

Antibiotic treatment adequacy and death among patients with Pseudomonas aeruginosa airway infection
por: Eklöf, Josefin, et al.
Publicado: (2019)

Adrenal suppression in patients with chronic obstructive pulmonary disease treated with glucocorticoids: Role of specific glucocorticoid receptor polymorphisms
por: Sivapalan, Pradeesh, et al.
Publicado: (2022)

High-pressure NIV for acute hypercapnic respiratory failure in COPD: improved survival in a retrospective cohort study
por: Hedsund, Caroline, et al.
Publicado: (2022)

Renin–angiotensin–system inhibitors and the risk of exacerbations in chronic obstructive pulmonary disease: a nationwide registry study
por: Vilstrup, Frida, et al.
Publicado: (2023)

Sedating antihistamine treatment with promethazine in patients with severe COPD with and without asthma: death and severe exacerbations in a nationwide register study
por: Bonnesen, Barbara, et al.
Publicado: (2023)

Management of COVID-19-Associated Acute Respiratory Failure with Alternatives to Invasive Mechanical Ventilation: High-Flow Oxygen, Continuous Positive Airway Pressure, and Noninvasive Ventilation
por: Bonnesen, Barbara, et al.
Publicado: (2021)

Acute Lung Injury in Critically Ill Patients: Actin-Scavenger Gelsolin Signals Prolonged Respiratory Failure
por: Holm, Freja Stæhr, et al.
Publicado: (2019)

Guideline for the management of COVID-19 patients during hospital admission in a non-intensive care setting
por: Nielsen Jeschke, Klaus, et al.
Publicado: (2020)

Targeted AntiBiotics for Chronic pulmonary diseases (TARGET ABC): can targeted antibiotic therapy improve the prognosis of Pseudomonas aeruginosa-infected patients with chronic pulmonary obstructive disease, non-cystic fibrosis bronchiectasis, and asthma? A multicenter, randomized, controlled, open-label trial
por: Eklöf, Josefin, et al.
Publicado: (2022)

Bone turnover biomarkers in COPD patients randomized to either a regular or shortened course of corticosteroids: a substudy of the randomized controlled CORTICO-COP trial
por: Sivapalan, Pradeesh, et al.
Publicado: (2020)

Risk of Chronic Obstructive Pulmonary Disease Exacerbation in Patients Who Use Methotrexate—A Nationwide Study of 58,580 Outpatients
por: Bergsøe, Christina Marisa, et al.
Publicado: (2021)

Long-term non-invasive ventilation for COPD patients following an exacerbation with acute hypercapnic respiratory failure: a randomized controlled trial
por: Hedsund, Caroline, et al.
Publicado: (2023)

Adherence to early pulmonary rehabilitation after COPD exacerbation and risk of hospital readmission: a secondary analysis of the COPD-EXA-REHAB study
por: Kjærgaard, Jakob, et al.
Publicado: (2020)

Hypoxemia and not hyperoxemia predicts worse outcome in severe COPD exacerbations - an observational study
por: Sandau, Charlotte, et al.
Publicado: (2022)

Calcium Channel Blockers and the Risk of Exacerbation in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Study of 48,488 Outpatients
por: Rastoder, Ema, et al.
Publicado: (2023)

Home Non Invasive Ventilation (NIV) treatment for COPD patients with a history of NIV-treated exacerbation; a randomized, controlled, multi-center study
por: Ankjærgaard, Kasper Linde, et al.
Publicado: (2016)

Biomarkers of Acute Lung Injury The Individualized Approach: for Phenotyping, Risk Stratification and Treatment Surveillance
por: Murray, Daniel D., et al.
Publicado: (2019)

Azithromycin and hydroxychloroquine in hospitalised patients with confirmed COVID-19: a randomised double-blinded placebo-controlled trial
por: Sivapalan, Pradeesh, et al.
Publicado: (2022)

Incidence of community-acquired pneumonia hospitalisation in persons with bronchiectasis during the COVID-19 lockdown in Denmark: a retrospective cohort study
por: Rømer, Valdemar, et al.
Publicado: (2023)

NIV for acute respiratory failure in COPD: high in-hospital mortality is determined by patient selection
por: Hedsund, Caroline, et al.
Publicado: (2019)

Automated oxygen control with O2matic(®) during admission with exacerbation of COPD
por: Hansen, Ejvind Frausing, et al.
Publicado: (2018)

Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial
por: Sivapalan, Pradeesh, et al.
Publicado: (2020)

Hydroxychloroquine as a primary prophylactic agent against SARS-CoV-2 infection: A cohort study
por: Kamstrup, Peter, et al.
Publicado: (2021)

TOB-STOP-COP (TOBacco STOP in COPd trial): study protocol—a randomized open-label, superiority, multicenter, two-arm intervention study of the effect of “high-intensity” vs. “low-intensity” smoking cessation intervention in active smokers with chronic obstructive pulmonary disease
por: Saeed, Mohamad Isam, et al.
Publicado: (2020)

The Impact of Social Distancing in 2020 on Admission Rates for Exacerbations in Asthma: A Nationwide Cohort Study
por: Toennesen, Louise Lindhardt, et al.
Publicado: (2022)

Risk of Malignancy in Patients with Asthma-COPD Overlap Compared to Patients with COPD without Asthma
por: Bonnesen, Barbara, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qoapl7na2iu38m0ldibc6b2bt5